INVESTMENT
Invest in the Next Generation of Patient Monitoring
Why Invest
Micro Flow Medix addresses an unmet global need:
continuous, non-invasive monitoring of hemoglobin mass and hydration — with strong IP protection, clinical traction, and billion-euro market potential.
Unmet Clinical Need
No competitor offers real-time, non-invasive Hb mass + hydration monitoring.
Strong IP Position
US & PCT patent applications filed.
Large Market
1 million
addressable installations in ICU/OR
€ 10B +
valued at
Recurring Revenue Model
Hardware + SaaS + service + potential data licensing.
Clear Path to Market
CE/FDA approvals targeted by 2029.
By redefining how clinicians monitor fluid and blood balance, Micro Flow Medix is establishing a new clinical standard — one with the potential to save millions of lives and reduce billions in healthcare costs.
